Image de couverture de livre

Risk prediction of mild cognitive impairment using electronic health record data

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Gang Li, Bryan Cobb, Todd M Nelson, Viswanath Devanarayan, Stephane Borentain, Michelle M. Mielke, James E Galvin, Miia Kivipelto, Rifky Tkatch, Susan De Santi, Feride Frech, Jo Vandercappellen, Yosuke Nakamura, Richard Crislip, Jeffrey Meyerhoff, Soeren Mattke, Harald Hampel
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Risk Factors for Mild Cognitive Impairment: Prediction Models Developed with Electronic Health Record Data
par: Gang Li, et autres
Publié: (2024)

Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
par: Hankyung Jun, et autres
Publié: (2026)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
par: Julius Opwonya, et autres
Publié: (2024)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
par: Elyse Couch, et autres
Publié: (2025)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
par: Simone Salemme, et autres
Publié: (2025)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
par: Sebastiaan De Keersmaecker, et autres
Publié: (2024)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
par: Adam H. Dyer, et autres
Publié: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
par: Kevin Duff, et autres
Publié: (2024)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Publié: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
par: Marieclaire Overton, et autres
Publié: (2025)

The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
par: Craig Ritchie, et autres
Publié: (2025)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
par: Jacqueline Chua, et autres
Publié: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
par: Sunu Mathew, et autres
Publié: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
par: Rachel R. Jin, et autres
Publié: (2025)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
par: Kay Jann, et autres
Publié: (2025)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
par: Gustavo Luis Verón, et autres
Publié: (2025)

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
par: Luwen Cao, et autres
Publié: (2024)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
par: Jessie T. Yan, et autres
Publié: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
par: María A. Rodríguez‐Santiago, et autres
Publié: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
par: Juliana N. Souza‐Talarico, et autres
Publié: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
par: Paul C. Donaghy, et autres
Publié: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
par: Felix Dörr, et autres
Publié: (2025)

An observational multi‐clinic implementation science study to evaluate barriers and enablers of real‐world use of confirmatory blood‐based biomarkers for the diagnosis of early Alzheimer’s disease
par: Leah Zullig, et autres
Publié: (2024)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
par: Yuhan Xie, et autres
Publié: (2025)

Real‐world use of lecanemab: patient pathway findings from a US multicenter study
par: Michael Rosenbloom, et autres
Publié: (2026)

Sex‐ and age‐specific effect of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population‐based Heinz Nixdorf Recall study
par: Anna Lena Platzbecker, et autres
Publié: (2025)

Dengue fever as a cause of hemophagocytic lymphohistiocytosis
par: Noely Hein
Publié: (2015)

Screening tools for oropharyngeal dysphagia in stroke
par: Tatiana Magalhães de Almeida
Publié: (2015)

Observational Study Evaluating Blood‐Based Biomarker Use for Confirmatory Alzheimer's Disease Diagnosis in Real‐World Clinical Practice Within the United States
par: Marwan N. Sabbagh, et autres
Publié: (2025)

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
par: Vicente Medel, et autres
Publié: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
par: Russell Banks, et autres
Publié: (2024)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
par: Samuel L. Warren, et autres
Publié: (2026)

Artificial intelligence detection of cognitive impairment in older adults during walking
par: Shuichi P. Obuchi, et autres
Publié: (2024)

Disentangling the effects of sex and gender on APOE ɛ4–related neurocognitive impairment
par: Tatiana Dessy, et autres
Publié: (2025)

Impact of dual sensory impairment on dementia: A systematic review and meta‐analysis
par: Daniele Urso, et autres
Publié: (2026)

Dementia stigma in the United States: variation by target gender, degree of impairment, and respondent characteristics
par: Lucas J. Hamilton, et autres
Publié: (2026)

Mild behavioral impairment in the general population aged 55+ and its association with incident dementia
par: Patricia Gracia‐García, et autres
Publié: (2024)

APOE ε4 allele status modulates the spatial patterns of progressive atrophy in the temporal lobes after mild traumatic brain injury
par: Shuoqiu Gan, et autres
Publié: (2024)

Feasibility of assessing cognitive impairment via distributed camera network and privacy‐preserving edge computing
par: Chaitra Hegde, et autres
Publié: (2025)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
par: Zheng Long Lee, et autres
Publié: (2026)